| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.69 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |